Short answer · Medically reviewed summary · Last updated: 2026-05-08
Burning Mouth Syndrome (BMS) is estimated to affect between 0.7% and 4.6% of the general population, though exact figures remain challenging to verify due to frequent underdiagnosis. While often categorized as a chronic condition rather than a rare disease, Burning Mouth Syndrome prevalence is significantly higher in postmenopausal women, with onset typically occurring in middle-aged or older adults. What is the estimated prevalence of Burning Mouth Syndrome? Epidemiological data for Burning Mouth Syndrome varies widely depending on the study population, with some clinical estimates suggesting a prevalence as high as 15% in specific geriatric cohorts.
Burning Mouth Syndrome (BMS) is estimated to affect between 0.7% and 4.6% of the general population, though exact figures remain challenging to verify due to frequent underdiagnosis. While often categorized as a chronic condition rather than a rare disease, Burning Mouth Syndrome prevalence is significantly higher in postmenopausal women, with onset typically occurring in middle-aged or older adults.
Epidemiological data for Burning Mouth Syndrome varies widely depending on the study population, with some clinical estimates suggesting a prevalence as high as 15% in specific geriatric cohorts. Because many patients are misdiagnosed or seek care across multiple specialties—including dentistry, neurology, and internal medicine—the true global burden of Burning Mouth Syndrome is likely higher than current reported statistics suggest.
Burning Mouth Syndrome exhibits a distinct demographic profile, showing a significant predilection for specific groups:
The diagnosis of Burning Mouth Syndrome is one of exclusion, meaning doctors must rule out other conditions like nutritional deficiencies, diabetes, or oral candidiasis first. This diagnostic complexity leads to significant underreporting. At DiseaseMaps.org, 21 people with Burning Mouth Syndrome have joined our community to share their experiences, providing a vital real-world perspective that clinical trials often miss by capturing the patient journey through chronic, often invisible, pain.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.